These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34494382)

  • 1. Spherical Nucleic Acid Vaccine Structure Markedly Influences Adaptive Immune Responses of Clinically Utilized Prostate Cancer Targets.
    Teplensky MH; Dittmar JW; Qin L; Wang S; Evangelopoulos M; Zhang B; Mirkin CA
    Adv Healthc Mater; 2021 Nov; 10(22):e2101262. PubMed ID: 34494382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy.
    Qin L; Wang S; Dominguez D; Long A; Chen S; Fan J; Ahn J; Skakuj K; Huang Z; Lee A; Mirkin C; Zhang B
    Front Immunol; 2020; 11():1333. PubMed ID: 32733447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.
    Vittes GE; Harden EL; Ottensmeier CH; Rice J; Stevenson FK
    Eur J Immunol; 2011 Aug; 41(8):2447-56. PubMed ID: 21604260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.
    Smith HA; McNeel DG
    J Immunother; 2011 Oct; 34(8):569-80. PubMed ID: 21904219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.
    Becker JT; Olson BM; Johnson LE; Davies JG; Dunphy EJ; McNeel DG
    J Immunother; 2010; 33(6):639-47. PubMed ID: 20551832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational vaccinology with spherical nucleic acids.
    Wang S; Qin L; Yamankurt G; Skakuj K; Huang Z; Chen PC; Dominguez D; Lee A; Zhang B; Mirkin CA
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10473-10481. PubMed ID: 31068463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.
    Durso RJ; Andjelic S; Gardner JP; Margitich DJ; Donovan GP; Arrigale RR; Wang X; Maughan MF; Talarico TL; Olmsted RA; Heston WD; Maddon PJ; Olson WC
    Clin Cancer Res; 2007 Jul; 13(13):3999-4008. PubMed ID: 17606734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-antigen spherical nucleic acid cancer vaccines.
    Teplensky MH; Evangelopoulos M; Dittmar JW; Forsyth CM; Sinegra AJ; Wang S; Mirkin CA
    Nat Biomed Eng; 2023 Jul; 7(7):911-927. PubMed ID: 36717738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
    Smith HA; Rekoske BT; McNeel DG
    Vaccine; 2014 Mar; 32(15):1707-15. PubMed ID: 24492013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination.
    Johnson LE; Olson BM; McNeel DG
    J Immunother Cancer; 2017 Jul; 5(1):56. PubMed ID: 28716080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of PSA and PSMA DNA vaccines with electroporation induces potent immune responses.
    Ferraro B; Cisper NJ; Talbott KT; Philipson-Weiner L; Lucke CE; Khan AS; Sardesai NY; Weiner DB
    Hum Vaccin; 2011; 7 Suppl():120-7. PubMed ID: 21266849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avidity characterization of genetically engineered T-cells with novel and established approaches.
    Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
    BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer vaccines: current status and future potential.
    Doehn C; Böhmer T; Kausch I; Sommerauer M; Jocham D
    BioDrugs; 2008; 22(2):71-84. PubMed ID: 18345705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning DNA Dissociation from Spherical Nucleic Acids for Enhanced Immunostimulation.
    Dittmar JW; Teplensky MH; Evangelopoulos M; Qin L; Zhang B; Mirkin CA
    ACS Nano; 2023 Sep; 17(18):17996-18007. PubMed ID: 37713675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.
    Matsueda S; Wang M; Weng J; Li Y; Yin B; Zou J; Li Q; Zhao W; Peng W; Legras X; Loo C; Wang RF; Wang HY
    PLoS One; 2012; 7(9):e45756. PubMed ID: 23029225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel DNA/peptide combined vaccine induces PSCA-specific cytotoxic T-lymphocyte responses and suppresses tumor growth in experimental prostate cancer.
    Zhang KQ; Yang F; Ye J; Jiang M; Liu Y; Jin FS; Wu YZ
    Urology; 2012 Jun; 79(6):1410.e7-13. PubMed ID: 22513035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
    Johnson LE; McNeel DG
    Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.